Elpais.com. The company Tecnoquímicas (TQ) ventured into the category of biosimilar drugs in the country, in alliance with the firm mAbxience, a European company specialized in research and development of this type of drug.
recently published
Horizon scanning
Jan 31 2024
Early Treatment: the role of biosimilars
18 2023 December
